Turyn Jacek, Matuszewski Marcin, Schlichtholz Beata
Department of Biochemistry, Medical University of Gdansk, Poland.
Oncol Rep. 2006 Jan;15(1):259-65.
Microsatellite alterations are a common feature of neoplastic cells. Our study aimed to compare the profile of microsatellite DNA alterations in tumor tissue and urine sediment at 12 selected microsatellite loci in transitional cell carcinoma of the bladder, and to determine which of the 12 markers or combination of markers has potential for the non-invasive diagnosis of bladder cancer. DNA alterations were examined using microsatellite markers on chromosomes 2p, 3p, 8p, 9p, 9q, 12q, 13q, 17p and 18q in 38 patients, including 12 with superficial Ta/T1 and 26 with muscle invasive T2-T4 bladder tumors. Microsatellite instability was a rare event in comparison with loss of heterozygosity and was related to a low rate of defects in mismatch repair genes. The sensitivity of microsatellite analysis was 75% (9/12) for Ta/T1 tumors and 69% (18/26) for T2-T4 tumors. Two tetranucleotide markers, D9S242 and D9S252, when combined, displayed microsatellite alterations in 59% (16/27) of microsatellite analysis-positive patients. DNA alterations were not detected in 21 non-tumor specimens. Twenty of 51 (39%) tumor DNA alterations were re-detected in urine sediments, and 7 alterations found in urine sediments were not found in the corresponding tumor specimens. No association was found between the DNA alterations and any of the prognostic parameters. However, the overall survival correlated with microsatellite alterations (P=0.04, log-rank test). These data suggest that markers at tetranucleotide repeats on chromosome 9q have particular diagnostic potential in bladder cancer. Moreover, microsatellite analysis is suitable for the selection of patients with a less favorable outcome.
微卫星改变是肿瘤细胞的一个常见特征。我们的研究旨在比较膀胱移行细胞癌中12个选定微卫星位点处肿瘤组织和尿沉渣中微卫星DNA改变的情况,并确定这12个标记物或标记物组合中哪些具有膀胱癌无创诊断的潜力。使用位于2号染色体p臂、3号染色体p臂、8号染色体p臂、9号染色体p臂、9号染色体q臂、12号染色体q臂、13号染色体q臂、17号染色体p臂和18号染色体q臂上的微卫星标记物,对38例患者进行DNA改变检测,其中包括12例表浅Ta/T1期和26例肌层浸润性T2 - T4期膀胱肿瘤患者。与杂合性缺失相比,微卫星不稳定性是一个罕见事件,且与错配修复基因的低缺陷率相关。微卫星分析对Ta/T1期肿瘤的敏感性为75%(9/12),对T2 - T4期肿瘤为69%(18/26)。两个四核苷酸标记物D9S242和D9S252联合使用时,在59%(16/27)的微卫星分析阳性患者中显示出微卫星改变。在21个非肿瘤标本中未检测到DNA改变。51例(39%)肿瘤DNA改变中有20例在尿沉渣中被重新检测到,在尿沉渣中发现的7例改变在相应肿瘤标本中未发现。未发现DNA改变与任何预后参数之间存在关联。然而,总生存与微卫星改变相关(P = 0.04,对数秩检验)。这些数据表明,9号染色体q臂上的四核苷酸重复标记物在膀胱癌中具有特殊的诊断潜力。此外,微卫星分析适用于选择预后较差的患者。